搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 天
Understanding COPD: Symptoms, types, causes and prevention tips
COPD (Chronic Obstructive Pulmonary Disease) is a lung disease that causes breathing difficulties, chronic cough, and mucus.
Rising Kashmir
10 天
Understanding COPD: A Chronic Lung Disease
Chronic obstructive lung disease, also known as chronic obstructive pulmonary disease (COPD), is a general term for a group ...
Everyday Health
2 天
FDA Approves Dupixent for Some Patients Struggling With COPD Symptoms
Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.
Medpage Today on MSN
2 天
First-Ever Biologic Approved for COPD
The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease ...
Managed Healthcare Executive
2 天
FDA Approves Dupixent for Patients with COPD
After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...
2 天
Sanofi blockbuster drug wins clearance in US for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
6 天
Causes and symptoms of poor lung health: Expert tips to prevent asthma, cancer, COPD in elders
Lung disease affects around 1 in 7 older persons, making it a serious health risk. Among persons 60 years of age and older, ...
FiercePharma
2 天
Sanofi, Regeneron look to seize major opportunity with Dupixent's COPD approval
After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...
6 天
Local father walking from Los Angeles to San Diego to raise awareness of rare disease
Eric Borstein is known as “The Walking Man,” and for good reason. He has Pulmonary Arterial Hypertension, a rare incurable ...
2 天
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients ...
Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...
HME News
2 天
NIV reconsideration: Try-and-fail recommendation causes concerns
WASHINGTON – Industry stakeholders are concerned that a recommendation to require COPD patients to try and fail on ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈